McKesson
U.S. healthcare supplies
McKesson is a multinational American healthcare industry company. The company is from Texas, and they are Number 8 on the Fortune 500, with more than $214 billion in annual revenue.[1]
 | |
 McKesson Plaza at 1 Post Street in San Francisco | |
| Type | Public |
|---|---|
| Headquarters | Irving, Texas, United States |
| Products | Pharmaceuticals
Medical technology Health care services |
Key people | Brian S. Tyler (CEO) |
The company is named in a federal lawsuit for making profit from epidemic in the United States.[2]
McKesson's contributions to the U.S. government's COVID-19 vaccine distribution efforts included serving as the centralized distributor for hundreds of millions of doses and assembling and distributing over 1 billion ancillary supply kits across the country.[3][4]
References
change- ↑ Leggate, James (2020-07-22). "What is McKesson?". FOXBusiness. Retrieved 2023-12-15.
- ↑ Leggate, James (2020-07-22). "What is McKesson?". FOXBusiness. Retrieved 2023-12-15.
- ↑ "Operation Warp Speed Selects McKesson for COVID-19 Vaccine Distribution". BioSpace. Retrieved 2023-12-16.
- ↑ "McKESSON REPORTS FISCAL 2022 FOURTH-QUARTER AND FULL-YEAR RESULTS" (PDF). McKesson. pp. 1–22.
This short article about the United States can be made longer. You can help Wikipedia by adding to it.